LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B2,590
Mkt Cap
$4.08BVolume
171,041.0052W High
$227.9252W Low
$93.58PE Ratio
35.06LGND Fundamentals
Price
$205.00Prev Close
$204.56Open
$206.6550D MA
$197.71Beta
0.99Avg. Volume
185,322.81EPS (Annual)
$6.13P/B
3.98Rev/Employee
$5.7M$3,554.96
Ligand Pharmaceuticals (NASDAQ:LGND) Director Stephen Sabba Sells 1,000 Shares
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) Director Stephen Sabba sold 1,000 shares of the business's stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $207.87, for a total value of $207,870.00. Following the sale, the director...
MarketBeat·9h ago
Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells 1,000 Shares of Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) Director Stephen Sabba sold 1,000 shares of the business's stock in a transaction that occurred on Monday, March 23rd. The shares...
MarketBeat·1d ago
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $276.00 at Citigroup
Citigroup boosted their price objective on Ligand Pharmaceuticals from $270.00 to $276.00 and gave the company a "buy" rating in a research note on Tuesday...
MarketBeat·2d ago
Congress Asset Management Co. Sells 187,248 Shares of Ligand Pharmaceuticals Incorporated $LGND
Congress Asset Management Co. lowered its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 28.1% during the 4th quarter, according to the company in its most...
MarketBeat·2d ago
Tudor Investment Corp ET AL Takes $2.79 Billion Position in Ligand Pharmaceuticals Incorporated $LGND
Tudor Investment Corp ET AL bought a new stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 15,750,000 shares of the biotech...
MarketBeat·7d ago
Penn Capital Management Company LLC Trims Position in Ligand Pharmaceuticals Incorporated $LGND
Penn Capital Management Company LLC trimmed its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 10.9% during the 3rd quarter, according to its most recent 13F...
MarketBeat·8d ago
Acuitas Investments LLC Trims Holdings in Ligand Pharmaceuticals Incorporated $LGND
Acuitas Investments LLC lowered its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 32.2% during the third quarter, according to the company in its most recent...
MarketBeat·9d ago
Granahan Investment Management LLC Purchases Shares of 24,962 Ligand Pharmaceuticals Incorporated $LGND
Granahan Investment Management LLC purchased a new position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the third quarter, according to the company in its most...
MarketBeat·9d ago
Clark Capital Management Group Inc. Acquires 11,858 Shares of Ligand Pharmaceuticals Incorporated $LGND
Clark Capital Management Group Inc. grew its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 16.7% during the third quarter, according to the company in its...
MarketBeat·10d ago
Octavio Espinoza Sells 3,057 Shares of Ligand Pharmaceuticals (NASDAQ:LGND) Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) CFO Octavio Espinoza sold 3,057 shares of Ligand Pharmaceuticals stock in a transaction dated Wednesday, March 11th. The stock was...
MarketBeat·12d ago
<
1
2
...
>